1. Home
  2. LSCC vs CYTK Comparison

LSCC vs CYTK Comparison

Compare LSCC & CYTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LSCC
  • CYTK
  • Stock Information
  • Founded
  • LSCC 1983
  • CYTK 1997
  • Country
  • LSCC United States
  • CYTK United States
  • Employees
  • LSCC N/A
  • CYTK N/A
  • Industry
  • LSCC Semiconductors
  • CYTK Biotechnology: Pharmaceutical Preparations
  • Sector
  • LSCC Technology
  • CYTK Health Care
  • Exchange
  • LSCC Nasdaq
  • CYTK Nasdaq
  • Market Cap
  • LSCC 6.8B
  • CYTK 5.6B
  • IPO Year
  • LSCC 1989
  • CYTK 2004
  • Fundamental
  • Price
  • LSCC $50.26
  • CYTK $33.58
  • Analyst Decision
  • LSCC Strong Buy
  • CYTK Buy
  • Analyst Count
  • LSCC 12
  • CYTK 14
  • Target Price
  • LSCC $63.58
  • CYTK $70.92
  • AVG Volume (30 Days)
  • LSCC 2.2M
  • CYTK 1.3M
  • Earning Date
  • LSCC 07-28-2025
  • CYTK 08-07-2025
  • Dividend Yield
  • LSCC N/A
  • CYTK N/A
  • EPS Growth
  • LSCC N/A
  • CYTK N/A
  • EPS
  • LSCC 0.37
  • CYTK N/A
  • Revenue
  • LSCC $488,736,000.00
  • CYTK $19,218,000.00
  • Revenue This Year
  • LSCC $3.41
  • CYTK $34.81
  • Revenue Next Year
  • LSCC $18.44
  • CYTK $643.79
  • P/E Ratio
  • LSCC $132.45
  • CYTK N/A
  • Revenue Growth
  • LSCC N/A
  • CYTK 412.21
  • 52 Week Low
  • LSCC $34.69
  • CYTK $29.31
  • 52 Week High
  • LSCC $70.55
  • CYTK $61.38
  • Technical
  • Relative Strength Index (RSI)
  • LSCC 47.11
  • CYTK 48.84
  • Support Level
  • LSCC $49.15
  • CYTK $31.99
  • Resistance Level
  • LSCC $52.09
  • CYTK $34.34
  • Average True Range (ATR)
  • LSCC 1.84
  • CYTK 1.24
  • MACD
  • LSCC -0.04
  • CYTK 0.12
  • Stochastic Oscillator
  • LSCC 30.20
  • CYTK 35.90

About LSCC Lattice Semiconductor Corporation

Lattice Semiconductor Corp is a developer of semiconductor technology that it distributes through products, solutions, and licenses. The company reaches its customers through consumer, communications, and industrial markets. The company has one operating segment namely the core Lattice business that includes silicon-based and silicon-enabling products, evaluation boards, development hardware, and related intellectual property licensing, services, and sales. The products of the company are offered globally; and, the majority of sales are derived from customers in Asia. It also has its presence in Americas and Europe.

About CYTK Cytokinetics Incorporated

Cytokinetics Inc is a biotechnology company that develops muscle biology-driven treatments for diseases characterized by reduced muscle function, muscle weakness, and fatigue. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary diseases. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.

Share on Social Networks: